Literature DB >> 2373569

Prediction of survival in patients with high-grade soft tissue sarcoma.

B Rööser1, N O Berg, J Ranstam, A Rydholm, H Willén.   

Abstract

Using the Cox proportional hazards model, and considering tumour necrosis and vascular invasion by tumour as additional factors in assessment, a series of 88 patients with primary Grade III and IV soft tissue sarcomas of the locomotor system was analysed for factors associated with death due to the tumour. Grade IV malignancy, a tumour size larger than 10 cm., tumour necrosis, and vascular invasion by tumour cells were significant risk factors. Patients with 0 or 1 risk factor, one half of the cases, had a 3 year survival rate of more than 90%, whereas the figure was 65% for those with 2 risk factors and 20% for those with 3 or 4 risk factors.

Entities:  

Mesh:

Year:  1990        PMID: 2373569     DOI: 10.1007/bf00180129

Source DB:  PubMed          Journal:  Int Orthop        ISSN: 0341-2695            Impact factor:   3.075


  20 in total

1.  A clinical and pathological staging system for soft tissue sarcomas.

Authors:  W O Russell; J Cohen; F Enzinger; S I Hajdu; H Heise; R G Martin; W Meissner; W T Miller; R L Schmitz; H D Suit
Journal:  Cancer       Date:  1977-10       Impact factor: 6.860

2.  Soft tissue sarcomas of the extremities: survival and patterns of failure with conservative surgery and postoperative irradiation compared to surgery alone.

Authors:  S A Leibel; R F Tranbaugh; W M Wara; J H Beckstead; E G Bovill; T L Phillips
Journal:  Cancer       Date:  1982-09-15       Impact factor: 6.860

3.  Myxofibrosarcoma. A malignant soft tissue tumor of fibroblastic-histiocytic origin. A clinicopathologic and prognostic study of 110 cases using multivariate analysis.

Authors:  C Merck; L Angervall; L G Kindblom; A Odén
Journal:  Acta Pathol Microbiol Immunol Scand Suppl       Date:  1983

4.  Adjuvant chemotherapy with doxorubicin in high-grade soft tissue sarcoma: a randomized trial of the Scandinavian Sarcoma Group.

Authors:  T A Alvegård; H Sigurdsson; H Mouridsen; O Solheim; B Unsgaard; U Ringborg; O Dahl; A M Nordentoft; C Blomqvist; A Rydholm
Journal:  J Clin Oncol       Date:  1989-10       Impact factor: 44.544

5.  Surgical treatment of 297 soft tissue sarcomas of the lower extremity.

Authors:  M H Shiu; E B Castro; S I Hajdu; J G Fortner
Journal:  Ann Surg       Date:  1975-11       Impact factor: 12.969

6.  A system for the surgical staging of musculoskeletal sarcoma.

Authors:  W F Enneking; S S Spanier; M A Goodman
Journal:  Clin Orthop Relat Res       Date:  1980 Nov-Dec       Impact factor: 4.176

7.  The grading of soft tissue sarcomas. Results of a clinicohistopathologic correlation in a series of 163 cases.

Authors:  J Costa; R A Wesley; E Glatstein; S A Rosenberg
Journal:  Cancer       Date:  1984-02-01       Impact factor: 6.860

8.  High-grade soft tissue sarcomas of the extremities.

Authors:  D A Potter; T Kinsella; E Glatstein; R Wesley; D E White; C A Seipp; A E Chang; E E Lack; J Costa; S A Rosenberg
Journal:  Cancer       Date:  1986-07-01       Impact factor: 6.860

9.  Survival in soft tissue sarcoma. Prognostic variables identified by multivariate analysis.

Authors:  B Rööser; R Attewell; N O Berg; A Rydholm
Journal:  Acta Orthop Scand       Date:  1987-10

10.  The staging of soft-tissue sarcomas.

Authors:  B Rööser; R Attewell; A Rydholm
Journal:  Int Orthop       Date:  1987       Impact factor: 3.075

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.